Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Baxter
Harvard Business School
McKinsey
Dow

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Litigation Details for BioDelivery Sciences International, Inc. v. Actavis Laboratories UT, Inc. (D. Del. 2016)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

BioDelivery Sciences International, Inc. v. Actavis Laboratories UT, Inc. (D. Del. 2016)

Docket   Start Trial Date Filed 2016-03-18
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties ACTAVIS LABORATORIES UT, INC.; ACTAVIS, INC.; ARIUS TWO, INC.; BIODELIVERY SCIENCES INTERNATIONAL, INC.
Patents 7,579,019; 8,147,866; 8,703,177
Attorneys Charles E. Lipsey; Courtney B. Casp; David P. Dalke; Emily Gabranski; Howard W. Levine; Jack B. Blumenfeld; Jeffrey D. Smyth; Jennifer S. Swan; Jonathan R. Davies; Maryellen Noreika; Melanie K. Sharp; Michael K. Nutter; Robert M. Vrana; Shilpa A. Coorg; Tyler G. Johannes
Firms Morris, Nichols, Arsht & Tunnell; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in BioDelivery Sciences International, Inc. v. Actavis Laboratories UT, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for BioDelivery Sciences International, Inc. v. Actavis Laboratories UT, Inc. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-03-18 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,019 B2; 8,147,866 B2; 8,703,177… 18 March 2016 1:16-cv-00175 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Merck
AstraZeneca
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.